 |
March 25, 2005
Fallout From Pharmaceutical Inventory Management Agreements
Study suggests IMAs produce opposite effect on healthcare system
By Thomas P. Gale
Inventory Management Agreements (IMAs), used for the past three years by drug manufacturers and wholesalers to reduce investment buying in the pharmaceutical channel, have had the opposite of their intended effect, according to research by Pembroke Consulting, Philadelphia, PA. The research data underscores the difficult transition distributors and manufacturers are navigating as they seek better profitability models.
Subscribers: click here for the full story
Non-Subscribers: click here to subscribe
Purchase Entire Issue (PDF Format)
|
